CD34 and neoplasm: To generate NSG mice with functional human T cells, human CD34+ HSCs were implanted subcutaneously into these mice.30–32 The successful generation of human immune cell populations in the NSG mice was validated by flow cytometry, and humanized mice with over 25% human CD45+ cell reconstitution were used for the tumor study (online supplemental figure S13).